Statements about H.R.4764: Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020

Eight members of Congress have made 12 statements about this bill.

Date	Member	Party	State / District	Title
Oct. 5, 2020	Albio Sires	D	NJ-8	Washington Review, October 5, 2020
Oct. 5, 2020	Rob Woodall	R	GA-7	Washington Watch - 10/5/20
Oct. 2, 2020	J. Luis Correa	D	CA-46	Weekly Wrap-up
Oct. 1, 2020	Michael C. Burgess	R	TX-26	Walden, Burgess on House Passage of 16 Bipartisan E&C Health Bills
Sept. 30, 2020	Doris Matsui	D	CA-7	House Passes Matsui's TRANSPLANT Act
Sept. 29, 2020	Steny H. Hoyer	D	MD-5	THE DAILY LEADER: WEDNESDAY, SEPTEMBER 30, 2020
Sept. 28, 2020	Steny H. Hoyer	D	MD-5	THE DAILY LEADER: TUESDAY, SEPTEMBER 29, 2020
Sept. 25, 2020	Steny H. Hoyer	D	MD-5	THE WEEKLY LEADER: FRIDAY, SEPTEMBER 25, 2020
July 29, 2020	Michael C. Burgess	R	TX-26	Burgess: Public Health Reauthorizations are a Bipartisan Priority
Oct. 21, 2019	Doris Matsui	D	CA-7	Matsui, Bilirakis, Pingree Introduce Life-Saving Stem Cell Therapeutic and Research Reauthorization Bill
Oct. 21, 2019	Chellie Pingree	D	ME-1	Reps. Pingree, Matsui, Bilirakis Introduce Bipartisan Life-Saving Stem Cell Therapeutic and Research Reauthorization Bill